Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller SC, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P, Reitz M.
Atzpodien J, et al. Among authors: soder m.
Br J Cancer. 2006 Aug 21;95(4):463-9. doi: 10.1038/sj.bjc.6603271. Epub 2006 Aug 8.
Br J Cancer. 2006.
PMID: 16909131
Free PMC article.
Clinical Trial.